| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/14/1998 | US5739160 Cyclopentane- and -pentene-β-amino acids |
| 04/14/1998 | US5739149 Treating asthma |
| 04/14/1998 | US5739147 Cyclohexane derivatives, process for their preparation, and the use of the compounds for the treatment of diseases |
| 04/14/1998 | US5739144 Trisubstituted phenyl derivatives |
| 04/14/1998 | US5739138 Modulators of cellular response |
| 04/14/1998 | US5739135 Inhibitors of microsomal triglyceride transfer protein and method |
| 04/14/1998 | US5739123 Phosphinic acid derivatives with metallopeptidase inhibitory activity |
| 04/14/1998 | US5739113 Injecting a composition comprising a bioactive material selected from prostaglandin e, growth hormone and growth factors and a controlled release matrix; expands, softens and restores elasticity |
| 04/14/1998 | US5739111 Modulating body/cranial hair growth with derivatives of the α-type melanocyte-stimulating hormone |
| 04/14/1998 | US5739110 Protection of hemopoietic cells |
| 04/14/1998 | US5739103 Mutants; antiinflammatory agents; anticholesterol agents; cardiovascular disorders; antiarthritic agents |
| 04/14/1998 | US5738873 Pharmaceutical formulations and methods for treating patients suffering from diseases that cause muscular hypotonia |
| 04/14/1998 | CA2138298C Pyridopyrimidinone antianginal agents |
| 04/10/1998 | CA2217810A1 2-aryl-3-aminoaryloxynaphthyl compounds, intermediates, compositions and methods |
| 04/10/1998 | CA2217571A1 1-aryloxy-2-arylnaphthyl compounds, intermediates, compositions and methods |
| 04/10/1998 | CA2217373A1 Benzo¬b|thiophene compounds, intermediates, formulations, and methods |
| 04/10/1998 | CA2217235A1 Benzo¬b|thiophene compounds, intermediates, formulations, and methods |
| 04/10/1998 | CA2217135A1 Benzo-b-thiophene compounds, intermediates, formulations, and methods |
| 04/09/1998 | WO1998014596A2 Disease associated protein tyrosine phosphatases |
| 04/09/1998 | WO1998014593A2 Human telomerase catalytic subunit |
| 04/09/1998 | WO1998014592A2 Telomerase reverse transcriptase |
| 04/09/1998 | WO1998014582A1 Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4) |
| 04/09/1998 | WO1998014572A1 Novel human phospholemman-like protein |
| 04/09/1998 | WO1998014479A1 Method of searching for physiologically active substances and process for producing the same |
| 04/09/1998 | WO1998014478A1 Continuous low-dose administration of parathyroid hormone or its agonist |
| 04/09/1998 | WO1998014450A1 Pyrimidine derivatives and processes for the preparation thereof |
| 04/09/1998 | WO1998014447A1 Novel indole-2,3-dione-3-oxime derivatives |
| 04/09/1998 | WO1998014436A1 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same |
| 04/09/1998 | WO1998014433A1 Aralkyl and aralkylidene heterocyclic lactams and imides |
| 04/09/1998 | WO1998014424A1 Hydroxamic acid derivatives |
| 04/09/1998 | WO1998014237A1 Skin battery cosmetic composition |
| 04/09/1998 | WO1998014215A2 Glycoconjugates as virus cell adhesion inhibitors |
| 04/09/1998 | WO1998014214A1 Methods for preventing, inhibiting or treating graft rejection reactions in graft-versus-host disease (gvhd) and organ transplantation |
| 04/09/1998 | WO1998014192A1 Vitronectin receptor antagonists |
| 04/09/1998 | WO1998014172A1 Inhibition of bcl-2 protein expression by liposomal antisense oligodeoxynucleotides |
| 04/09/1998 | DE19740733A1 Powder composition containing absorbent resin and peptide |
| 04/09/1998 | CA2645721A1 Human telomerase reverse transcriptase |
| 04/09/1998 | CA2268953A1 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same |
| 04/09/1998 | CA2267664A1 Human telomerase reverse transcriptase |
| 04/09/1998 | CA2267415A1 Hydroxamic acid derivatives |
| 04/09/1998 | CA2267193A1 Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4) |
| 04/09/1998 | CA2266752A1 Telomerase reverse transcriptase |
| 04/09/1998 | CA2265449A1 Disease associated protein tyrosine phosphatases |
| 04/09/1998 | CA2265447A1 Novel human phospholemman-like protein |
| 04/09/1998 | CA2217846A1 A combination preparation containing tramadol and a calcium channel antagonist |
| 04/08/1998 | EP0834562A1 Polypetide exhibiting calpain inhibition activity and method for the preparation thereof |
| 04/08/1998 | EP0834556A1 Methods for culturing cells |
| 04/08/1998 | EP0834510A2 Flavone derivative and medicine comprising the same |
| 04/08/1998 | EP0834508A1 Substituted biphenyl or phenylpyridine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 04/08/1998 | EP0834313A1 Therapeutic treatment for central nervous system diseases associated with HIV infection |
| 04/08/1998 | EP0834311A1 Method for inhibiting the growth of mammalian cells |
| 04/08/1998 | EP0833909A1 Protein with differentiation-inducing activity for friend's erythroleukemia cell lines |
| 04/08/1998 | EP0833899A1 Cis-9,10-octadecenoamidase |
| 04/08/1998 | EP0833844A1 SINGLE CHAIN ANALOGS OF THE TGF-$g(b) SUPERFAMILY (MORPHONS) |
| 04/08/1998 | EP0833843A2 Depigmenting activity of agouti signal protein and peptides thereof |
| 04/08/1998 | EP0833839A1 Peptidyl heterocycles useful in the treatment of thrombin related disorders |
| 04/08/1998 | EP0833837A1 Process for preparing derivatives of azabicyclo naphthyridine carboxylic acid comprising a dipeptide |
| 04/08/1998 | EP0833828A1 Rapamycin derivatives |
| 04/08/1998 | EP0833826A1 Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease |
| 04/08/1998 | EP0833818A1 Cb 2? receptor agonist compounds |
| 04/08/1998 | EP0833665A1 Compositions containing nucleic acids and ligands for therapeutic treatment |
| 04/08/1998 | EP0833664A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b 4? receptor antagonist for the treatment of inflammations |
| 04/08/1998 | EP0833659A1 Therapeutic fragments of von willebrand factor |
| 04/08/1998 | EP0833643A1 Anhydrous alendronate monosodium salt formulations |
| 04/08/1998 | EP0833639A1 Phenoxy piperazine derivatives for treating disorders of the dopamine system |
| 04/08/1998 | EP0833638A1 USE OF IMIDAZO 1,5-a]QUINOLONES AS NEUROPROTECTIVE AGENTS |
| 04/08/1998 | EP0833635A1 Novel use for pyrrole derivatives |
| 04/08/1998 | EP0833630A1 Novel benzopyran compounds and methods for their use |
| 04/08/1998 | EP0833629A2 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors |
| 04/08/1998 | EP0833626A1 Mono- and disulfo-substituted anthraquinones and their use for the treatment of bone matrix disorders |
| 04/08/1998 | EP0833622A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 04/08/1998 | EP0833620A1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells |
| 04/08/1998 | EP0833570A1 Therapeutic system for dietary health management |
| 04/08/1998 | EP0630405B1 Novel V28 seven transmembrane receptor |
| 04/08/1998 | EP0558681B1 Treatment for tissue ulceration |
| 04/08/1998 | EP0558630B1 Retroviral protease inhibitors |
| 04/08/1998 | EP0512042B1 Glp-1 analogs useful for diabetes treatment |
| 04/08/1998 | CN1178529A Heterocyclic subsitituted piperazinone derivatives as tachykinin receptor antagonists |
| 04/08/1998 | CN1178462A Methods and pharmaceutical compostions employing desmethylselegiline |
| 04/08/1998 | CN1178461A Pharmaceutical compositions comprising monoamine oxidase B inhibitors |
| 04/08/1998 | CN1037966C Production of 4 -(5, 6, 7, 8 -tetrahydroimidazo £1.5-a| pyridine -5 -group) benzonitrile acidified hemihydrate |
| 04/07/1998 | US5736578 Treatment of sleep disorders |
| 04/07/1998 | US5736574 Comprising a hydrolipid and at least one glyceryl monoalkyl ether |
| 04/07/1998 | US5736570 Administering to reduce tumor necrosis factor (tnfa) levels in mammal; retroviral disease treatment/prophylaxis |
| 04/07/1998 | US5736564 Endothelin receptor antagonists |
| 04/07/1998 | US5736563 Transcutaneous in vivo activation of photosensitive agents in blood |
| 04/07/1998 | US5736562 Modify function of serotonin in mammals |
| 04/07/1998 | US5736560 Useful in the treatment of alzheimer's and parkinsons's diseases |
| 04/07/1998 | US5736556 Parkinson*s disease; antidepressants; antiobesity; antinarcolepsy; drug abruse |
| 04/07/1998 | US5736555 Hypotensive agents; fda orange book listed patent for azilsartan medoxomil |
| 04/07/1998 | US5736543 Benzoxazines for enhancing synaptic response |
| 04/07/1998 | US5736539 Inhibitors of farnesyl-protein transferase |
| 04/07/1998 | US5736536 Method for treating vascular leak syndrome |
| 04/07/1998 | US5736522 Chondoprotective agent |
| 04/07/1998 | US5736396 Lineage-directed induction of human mesenchymal stem cell differentiation |
| 04/07/1998 | CA2217409A1 Pharmaceutical preparations for intranasal administration |
| 04/07/1998 | CA2130116C Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| 04/07/1998 | CA1339802C Diarylstrylquinoline diacids |
| 04/03/1998 | CA2216265A1 Method for inhibiting the growth of mammalian cells |
| 04/02/1998 | WO1998013493A2 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |